Common questions about Paracodina (FAQ)
Q: Is Paracodina the same as codeine?
Dihydrocodeine, the active ingredient in Paracodina, is classified in official documents as a semi-synthetic opioid and a derivative of codeine. This means the substances are chemically related and share a similar structure and mechanism of action, but they are chemically distinct.
Q: What does 'opiate derivative' mean in relation to Paracodina?
The official product information identifies the active ingredient as a semi-synthetic opioid. This classification indicates that the substance is chemically prepared from natural opiates, like codeine, which originate from the opium poppy.
Q: Are there any long-term effects associated with using Paracodina?
Long-term, regular use of any opioid is associated with a risk of developing physical or psychological dependence, or addiction. Official warnings also note that prolonged use of opioids is associated with risks such as hormonal dysfunction and changes in central nervous system function.
Q: How is Paracodina different from similar cough suppressants?
Paracodina's active ingredient, dihydrocodeine, is an opioid that works centrally to address the cough reflex. It achieves this by acting directly on the cough center in the brain. Non-opioid suppressants, in contrast, utilize different pharmacological pathways to address coughing.
Q: Why do official documents state that Paracodina is for short-term use?
Official regulatory labels state that the medicine is intended for short-term use only. This restriction is advised due to the established risk of dependence and medication overuse headache when used for more than three consecutive days.
Q: What kind of cough is Paracodina approved to treat?
The medicine is approved as an antitussive, which means its purpose is to address coughing. Official prescribing information focuses on its use for persistent, centrally-mediated coughing, which is cough originating from the brain's cough center.
Q: Can Paracodina affect driving or operating machinery?
Yes, official product information indicates that dihydrocodeine may impair the mental and physical abilities required for potentially hazardous tasks. Official warnings state that due to the potential for impairment, activities such as driving a car or operating heavy machinery should be avoided if affected by drowsiness or dizziness.
Q: What should I know about taking Paracodina with antidepressants?
Regulatory documents state that dihydrocodeine is contraindicated for use with Monoamine Oxidase Inhibitors (MAOIs). The medicine also interacts with certain other antidepressants that inhibit the CYP2D6 enzyme, which can alter the drug's processing, potentially changing the body's exposure to the medicine or its active metabolite.
Q: Is there a maximum time frame for how long Paracodina should be used?
Yes, official regulatory constraints limit continuous use to no more than three days without a medical re-evaluation, due to the documented risk of dependence. This warning is in place to minimize the risk of developing addiction and overuse headache.
Q: Are there specific food items that interact with Paracodina?
While specific food-drug interactions are not widely highlighted in core regulatory documents, Official regulatory documents mention that the medicine is generally taken with or soon after food or a snack. This context is described to help reduce the potential for stomach discomfort.
Q: Why do some people experience constipation with Paracodina?
Constipation is listed as a common side effect in official safety documents for the active ingredient. This occurs because the dihydrocodeine works by slowing down the normal movement and activity of the digestive system.
Q: Can Paracodina be taken with common pain relievers like ibuprofen?
Co-administration with non-opioid pain relievers such as paracetamol or ibuprofen is not generally listed as restricted in available regulatory guidance. This means the combination is not typically contraindicated by official sources.
Q: How quickly can I expect Paracodina to start working?
Official regulatory documents do not state an exact time of onset for the drug's action. However, the drug is labeled for use at intervals typically ranging from 4 to 6 hours for immediate-release forms, which provides a general timeframe for the expected duration of the effect.
Q: Is Paracodina considered a controlled substance?
Yes, due to its classification as an opioid and semi-synthetic codeine derivative, the drug is regulated as a controlled substance or Drug of Dependence. This status means it is subject to specific legal requirements regarding prescribing, storage, and disposal.
Q: Is Paracodina known to interact with herbal supplements?
Regulatory bodies advise that there is insufficient evidence to confirm safety when the drug is taken alongside herbal remedies and supplements. In such cases, official guidance directs patients to seek advice from their prescribing doctor or pharmacist.
Q: How long does the effect of Paracodina usually last?
The duration of the expected effect depends on the specific formulation being used. For example, immediate-release forms are generally labeled for use at 4 to 6-hour intervals, while prolonged-release tablets are generally taken at 12-hour intervals, providing the labeled timeframe for the effect.
Q: What happens if I miss a scheduled time for Paracodina?
Official patient instructions provide specific guidance to skip the missed administration and take the subsequent dose at the regularly scheduled time. The guidance explicitly cautions against taking a double quantity to make up for the missed one.
Q: Does Paracodina show up on standard drug tests?
Yes, as dihydrocodeine is classified as an opiate, it may be detected in standard drug screenings for opiates. Regulatory and toxicology information indicates it can be detectable for up to 3 days after administration.
Q: Does the efficacy of Paracodina decrease with repeated use?
Official opioid warnings indicate that with repeated use, the body may develop a phenomenon known as tolerance. This means that over time, the initial dose may become less effective, which is a factor that can lead to increased dose requirements and risk of dependence.
Q: What should I do if I suspect an interaction between Paracodina and another drug?
Official patient information directs that if a person suspects an interaction between medicines, professional guidance should be immediately sought from the prescribing doctor or pharmacist.
